PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer

ABSTRACT:

SUBMITTER: Pasaol J 

PROVIDER: S-EPMC12228278 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature